Aziyo Biologics Inc.

NASDAQ: AZYO · Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM

Aziyo Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.24M 16.99M 30.43M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
n/a n/a 76K
Receivables
2.28M 6.83M 6M
Inventory
3.91M 10.05M 9.55M
Other Current Assets
6.75M 16.83M 1.49M
Total Current Assets
26.17M 50.7M 47.43M
Property-Plant & Equipment
1.68M 3.07M 1.2M
Goodwill & Intangibles
8.27M 15.07M 18.47M
Total Long-Term Assets
9.96M 18.14M 19.74M
Total Assets
36.13M 68.84M 67.17M
Account Payables
4.15M 2.33M 1.58M
Deferred Revenue
n/a n/a 5K
Short-Term Debt
1.71M 682K 15.57M
Other Current Liabilities
31.94M 39.6M 8.84M
Total Current Liabilities
37.8M 42.62M 26M
Long-Term Debt
28.52M 31.13M 10.41M
Other Long-Term Liabilities
16.08M 127K 17.24M
Total Long-Term Liabilities
44.59M 31.26M 27.65M
Total Liabilities
82.39M 73.87M 53.65M
Total Debt
30.23M 34.89M 25.98M
Common Stock
35K 16K 13K
Retained Earnings
-229.59M -137.99M -105.09M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
-46.26M -5.03M 13.52M
Total Investments
n/a n/a n/a